Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NP | MRSH |
|---|---|---|
| Price | $27.12 | $170.43 |
| Change today | ▼ 1.13% | ▲ 0.22% |
| Market cap | $3.72B | $81.33B |
| Return, 3 months | -19.7% | -3.7% |
| Return, year to date | -7.0% | -6.7% |
| Return, 1 year | -9.6% | -14.0% |
| P/E (TTM) | 99.3 | 20.8 |
| P/B | -16.8 | 5.4 |
| P/E percentile vs own 5y | – | 10th |
| Dividend yield | – | 2.11% |
| Revenue growth (YoY, latest qtr) | +32.8% | +6.2% |
| Net profit growth (YoY) | +35.9% | +4.9% |
| Gross margin | 55.3% | 42.4% |
| Operating margin | 47.5% | 21.6% |
| Net margin | 28.3% | 14.2% |
| Return on equity | – | 25.7% |
| Analyst target vs. price | +28.2% | +19.7% |
| Analyst buy share | 67% | 33% |
| RSI (14) | 30 | 38 |
| 30-day volatility | 26.9% | 18.4% |
| Max drawdown, 1 year | -43.8% | -23.2% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
